bf/NASDAQ:RNAZ_icon.jpeg

NASDAQ:RNAZ

TransCode Therapeutics

  • Stock

USD

Last Close

0.88

17/05 20:00

Market Cap

476.80K

Beta: -

Volume Today

3.90M

Avg: 1.67M

PE Ratio

−0.06

PFCF: −0.23

Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
cash per share
0.80
-
2.59
225.20%
49.43
1,805.48%
0.38
99.23%
15.46
3,938.31%
company equity multiplier
-0.18
-
-0.31
68.07%
1.12
463.05%
2.34
108.28%
3.15
34.56%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
1.33
-
3.23
142.71%
1.11
65.51%
0.94
15.42%
1
6.27%
effective tax rate
-0.26
-
-0.17
34.89%
-0.01
91.74%
-1
7,098.27%
enterprise value multiple
-46.47
-
-36.88
20.63%
-0.10
99.73%
-9.72
9,735.76%
0.06
100.63%
fixed asset turnover
free cash flow per share
-1.98
-
-1.54
22.15%
-13.11
748.58%
-1.22
90.67%
-100.97
8,160.09%
gross profit margin
interest coverage
-2.91
-
-1.84
36.73%
-64.70
3,413.51%
-1.06
98.36%
331.78
31,321.15%
inventory turnover
long term debt to capitalization
-5.10
-
-1.58
69.03%
0.02
-
net income per ebt
1.26
-
1.17
7.16%
1.01
13.22%
2
97.26%
1
50%
net profit margin
operating cash flow per share
-1.98
-
-1.54
22.15%
-12.50
709.42%
-1.21
90.28%
-100.97
8,212.97%
operating profit margin
payables turnover
pretax profit margin
price fair value
-18.48
-
-7.49
59.45%
1.05
114.00%
53.90
5,038.81%
0.72
98.67%
receivables turnover
return on assets
-3.74
-
-2.59
30.57%
-0.30
88.34%
-4.63
1,430.56%
-3.59
22.51%
return on capital employed
-3.23
-
-1.12
65.40%
-0.30
73.01%
-5.76
1,810.63%
-11.05
91.76%
return on equity
0.69
-
0.80
16.69%
-0.34
142.32%
-10.84
3,087.85%
-11.30
4.27%
total debt to capitalization
-5.10
-
-1.58
69.03%
0.22
-

All numbers in USD (except ratios and percentages)